Dystonic DisordersDystoniaMovement DisordersDystonia Musculorum DeformansTorticollisChoreaMovementAthetosisBipolar DisorderMental DisordersBlepharospasmTremorAnti-Dyskinesia AgentsAnxiety DisordersParkinson DiseaseMood DisordersGlobus PallidusMyoclonusBasal GangliaMeige SyndromeDeep Brain StimulationEssential TremorParkinsonian DisordersDyskinesia, Drug-InducedDiagnostic and Statistical Manual of Mental DisordersHandwritingDyskinesiasBasal Ganglia DiseasesInfusions, SpinalDepressive Disorder, MajorElectromyographyEye MovementsHandAttention Deficit Disorder with HyperactivityNocturnal Myoclonus SyndromeMuscle CrampLevodopaDepressive DisorderTic DisordersBotulinum ToxinsObsessive-Compulsive DisorderPsychotic DisordersBrainEntopeduncular NucleusAutistic DisorderStress Disorders, Post-TraumaticNeuroacanthocytosisStereotypic Movement DisorderNeck MusclesPhobic DisordersChild Development Disorders, PervasiveSubstance-Related DisordersPedigreeSleep DisordersSyndromeStereotaxic TechniquesAtaxiaAge of OnsetPsychiatric Status Rating ScalesMetoclopramidePsychophysiologic DisordersCognition DisordersConduct DisorderMutationMotor CortexDisease Models, AnimalMagnetic Resonance ImagingPsychomotor DisordersSeverity of Illness IndexRats, Mutant StrainsHarmalineSleep-Wake Transition DisordersNeurologic ExaminationAntiparkinson AgentsNeurologyAntipsychotic AgentsPsychomotor PerformanceBorderline Personality DisorderAkathisia, Drug-InducedComorbidityMolecular ChaperonesNeuromuscular AgentsSomatoform DisordersElectroencephalographyPhenotypeSchizophreniaCerebral PalsyNervous System DiseasesFacial InjuriesBotulinum Toxins, Type ATreatment OutcomeSleep Disorders, IntrinsicHyperkinesisHead MovementsMultiple System AtrophyNeuronsOcular Motility DisordersLymphoproliferative DisordersMice, Neurologic MutantsCorpus Striatum